Plouin P F, Morgado Vital A, Alhenc-Gelas F, Ménard J
Nouv Presse Med. 1979 Oct 15;8(39):3135-8.
We substituted minoxidil for dihydralazine in the treatment of 10 patients with refractory hypertension. Supine diastolic blood pressure decreased from 114 +/- 15 mmHg ou dihydralazine to 90 +/- 10 mmHg after one week on minoxidil (mean +/- ISD, p less than 0.01), the concomitant therapy being unchanged (sodium depletion and betablockade in all patients, methyl dopa or clonidine in seven). Simultaneously themean plasma volume increased by 395 ml (p less than 0.02) with no correlation to the decrease in blood pressure, and with no change in plasma renin activity and plasma aldosterone. Further expansion of plasma volume was prevented by furosemide, individual dosage requirement ranging from 40 to 500 mg/day, irrespective of the renal function. fter three to six months of ambulatory treatment a satisfactory blood pressure control was maintained. Hirsuties appeared in all our patients, but no subjective side effects was reported.
我们用米诺地尔替代双肼屈嗪治疗10例顽固性高血压患者。使用双肼屈嗪时仰卧位舒张压为114±15mmHg,使用米诺地尔一周后降至90±10mmHg(均值±标准差,p<0.01),同时治疗不变(所有患者均有钠缺失和β受体阻滞剂治疗,7例患者使用甲基多巴或可乐定)。同时,平均血浆容量增加395ml(p<0.02),与血压下降无关,血浆肾素活性和血浆醛固酮无变化。速尿可防止血浆容量进一步增加,无论肾功能如何,个体剂量需求为40至500mg/天。门诊治疗三至六个月后,血压维持在满意的控制水平。所有患者均出现多毛症,但未报告主观副作用。